FDA Inspection 1025933 — Actavis Pharma Development Centre Private Ltd
The FDA completed an inspection of Actavis Pharma Development Centre Private Ltd on Sep 21, 2017 in Chennai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 21, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Chennai (India)
Citations
| ID | CFR | Description |
|---|---|---|
| 1920 | 21 CFR 211.166(a)(3) | Valid stability test methods |
| 4403 | 21 CFR 211.194(b) | Test method modification records do not include |